Effect of resveratrol and curcumin and the potential synergism on hypertension: A mini‐review of human and animal model studies
Zahra Ghaeini Hesarooeyeh, Ayoub Basham, MohammadHosein Sheybani‐Arani, Mahshid Abbaszadeh, Ali Salimi Asl, Meysam Moghbeli, Ehsan Saburi
Abstract
Resveratrol (RES) and curcumin (CUR) are two of the most extensively studied bioactive compounds in cardiovascular research from the past until today. These compounds have effectively lowered blood pressure by downregulating the renin-angiotensin system, exerting antioxidant effects, and exhibiting antiproliferative activities on blood vessels. This study aims to summarize the results of human and animal studies investigating the effects of CUR, RES, and their combination on hypertension and the molecular mechanisms involved. The published trials' results are controversial regarding blood pressure reduction with different doses of RES and CUR, highlighting the need to address this issue.